Simplex Trading
LFCR icon

Simplex Trading’s Lifecore Biomedical LFCR Stock Holding History

Simplex Trading’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.86K Buy
+500
New +$3.45K ﹤0.01% 8397
2025
Q4 		– Sell
-500
Closed -$3K – 9376
2025
Q3 		$3K Sell
500
-2,800
-85% -$21.2K ﹤0.01% 8518
2025
Q2 		$26K Buy
3,300
+1,900
+136% +$12.8K ﹤0.01% 6534
2025
Q1 		$9K Sell
1,400
-2,100
-60% -$13.1K ﹤0.01% 7173
2024
Q4 		$26K Sell
3,500
-2,400
-41% -$15.3K ﹤0.01% 6470
2024
Q3 		$29K Sell
5,900
-6,500
-52% -$34K ﹤0.01% 6385
2024
Q2 		$63K Sell
12,400
-4,500
-27% -$26.6K ﹤0.01% 5839
2024
Q1 		$89K Buy
16,900
+15,900
+1,590% +$114K ﹤0.01% 5707
2023
Q4 		$6K Sell
1,000
-27,400
-96% -$190K ﹤0.01% 7762
2023
Q3 		$214K Sell
28,400
-3,700
-12% -$33.8K ﹤0.01% 4269
2023
Q2 		$310K Buy
+32,100
New +$196K ﹤0.01% 3802
2022
Q3 		– Sell
-600
Closed -$5K – 10447
2022
Q2 		$5K Hold
600
– – ﹤0.01% 8834
2022
Q1 		$6K Buy
+600
New +$6.68K ﹤0.01% 9296
2021
Q4 		– Sell
-1,000
Closed -$11K – 10970
2021
Q3 		$11K Hold
1,000
– – ﹤0.01% 8871
2021
Q2 		$11K Buy
1,000
+977
+4,248% +$11.3K ﹤0.01% 9037
2021
Q1 		$24K Buy
23
+13
+130% +$146 ﹤0.01% 7309
2020
Q4 		$10K Sell
10
-3
-23% -$31 ﹤0.01% 7411
2020
Q3 		$12K Sell
13
-6
-32% -$57 ﹤0.01% 6705
2020
Q2 		$15K Buy
+19
New +$196 ﹤0.01% 6415
2020
Q1 		– Sell
-316
Closed -$357K – 7946
2019
Q4 		$357K Buy
+316
New +$3.36K ﹤0.01% 3087
2016
Q4 		– Sell
-24
Closed -$1K – 6214
2016
Q3 		$1K Buy
+24
New +$291 ﹤0.01% 5355

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's LFCR Position: Q1 2026 in Review

Simplex Trading increased its Lifecore Biomedical (LFCR) stake by 373% in Q1 2026, buying an estimated $34.2K and bringing the position to 6,277 shares worth $23.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6646.

Simplex Trading first reported a position in LFCR in Q4 2016 and has held it in 26 quarters since. The position peaked at $534K in Q2 2023. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • Simplex Trading held 6,277 shares of Lifecore Biomedical worth $23.4K as of Q1 2026.
  • Simplex Trading bought 4,949 Lifecore Biomedical shares in Q1 2026, an estimated $34.2K.
  • Lifecore Biomedical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6646 holding.
  • Simplex Trading first reported a position in Lifecore Biomedical in Q4 2016 and has held it in 26 quarters since.
  • Simplex Trading's Lifecore Biomedical position peaked at $534K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.